Showing results (1081-1090 of 1,666) with videos related to

Sort By:
Pageof 167
British Journal of Clinical Pharmacology|April 6, 2021
Randomised, phase I pharmacokinetic study of adalimumab biosimilar CT-P17 (40 mg/0.4 mL) by autoinjector and prefilled syringe in healthy subjectsAntonia Davidson, Darin Brimhall, Jonathan Kay, et al.
Parasitology Research|March 16, 2023
Experimental keratitis induced in rat by Acanthamoeba from distinct morphological groups/genotypes: a histological and immunohistochemical evaluationNorberto de Souza Fernandes, Marcelo Vidigal Caliari, Fabricio Marcos Silva Oliveira, et al.
Molecular Systems Biology|March 17, 2026
A universal surface functionalization technique to chemically enhance live microbial cellsGabriel T Vercelli, Xingcheng Zhou, Stefany Moreno-Gámez, et al.
The Journal of Rheumatology|July 5, 2011
Minimally important differences of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract InstrumentDinesh Khanna, Daniel E Furst, Paul Maranian, et al.
BMC Health Services Research|May 14, 2025
Shifting the focus of child and youth wellbeing programs from crisis to prevention: a mixed methods study of the role of First Nations' community-controlled organisationsJanya McCalman, Merissa Nona, Mandy Edwards, et al.
Wellcome Open Research|October 21, 2024
A protocol for a living mapping review of global research funding for infectious diseases with a pandemic potential - Pandemic PACTOlena Seminog, Rodrigo Furst, Thomas Mendy, et al.
Sleep Medicine|September 16, 2023
Behavioral and psychological treatments for NREM parasomnias: A systematic reviewJennifer M Mundt, Matthew D Schuiling, Chloe Warlick, et al.
Drug and Alcohol Dependence|June 4, 2018
Varenicline treatment for methamphetamine dependence: A randomized, double-blind phase II clinical trialMarisa Briones, Steven Shoptaw, Ryan Cook, et al.
The Journal of Rheumatology|May 22, 2001
Standardizing assessment of adverse effects in rheumatology clinical trials. Status of OMERACT Toxicity Working Group March 2000: towards a common understanding of comparative toxicity/safety profiles for antirheumatic therapiesT G Woodworth, D E Furst, V Strand, et al.
The Journal of Rheumatology|August 3, 2011
OMERACT 10 Patient Perspective Virtual Campus: valuing health; measuring outcomes in rheumatoid arthritis fatigue, RA sleep, arthroplasty, and systemic sclerosis; and clinical significance of changes in healthJohn R Kirwan, Annelies Boonen, Mark J Harrison, et al.
Pageof 167